Valneva’s chikungunya jab gets FDA nod, first such for disease
HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals
HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals
HQ Team November 9, 2023: Eli Lilly’s weight-loss injection Zepbound, to be taken along as a supplement with diet and exercise, got the
More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people
Last year about 7.5 million people had tuberculosis (TB), the world’s second-most infectious killer, and multi-drug resistant form of the disease remains a
Otsuka Medical Devices Co., announced its treatment for hypertension has got approval from the US Food and Drug Administration.
HQ Team November 7, 2023: Shareholders of Abcam Plc., a UK-based manufacturer and supplier of antibodies and reagents used for medical research, have
By Dr K. Leelamoni November 7, 2023: My cousin’s son, 46, went to a hospital in the southern Indian state of Kerala as
HQ Team November 6, 2023: The USFDA plans to revoke a regulation authorising the use of brominated vegetable oil in food as it